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Introduction 75
Vector-borne diseases such as those transmitted by mosquitoes have a major impact 76 on human and animal health. Among the many examples, malaria (caused by 77
Plasmodium parasites) and dengue (caused by four serotypes of dengue virus, 78
Flaviviridae) stand out as major diseases that affect populations worldwide, but new 79 threats such chikungunya virus (Togaviridae) and more recently Zika virus 80 (Flaviviridae) have emerged [1] [2] [3] [4] . Both known and emerging pathogens put huge 81 pressure on communities and public health systems. Vaccine development against 82 key threats to human health such as dengue virus and Plasmodium parasites may 83 offer tools against transmission and disease, and progress is encouraging [5] [6] [7] [8] . 84
However, issues such as pathogen strain variation and vaccine or drug 85 production/distribution costs will remain as challenges [9] , and even with vaccines 86 vector control will be a crucial part of a multivalent arsenal. Although drugs against 87 malaria parasites are on the market, availability, administration and resistance are 88 problematic [10] [11] [12] . Drugs targeting dengue virus are in the development stages 89 [13] [14] [15] [16] . In the case of chikungunya virus vaccine candidates and drugs are now in 90 development [17] . Only veterinary vaccines are currently in use for the animal 91 pathogen Rift Valley fever virus (Bunyaviridae) and efforts to produce human 92 vaccines are urgently needed [18, 19] . 93
Many ongoing efforts to control vector-borne diseases rely on control measures that 94 target mosquitoes including control of larval breeding sites, use of insecticides, use 95 of bed nets (often used in combination with insecticides) (see for example, [20-25]) . 96
These efforts have been successful when implemented consistently, although issues 97 such as insecticide resistance, changes in vector behavior, and difficulties with 98 breeding site control (see for example [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] ) require that research in vector 99 biology and control is continuously developed and strengthened. Technological 100 developments over the last decade are transforming modern vector research. These 101 include: vector genome sequences, high-throughput genomics, transcriptomics, and 102 population genetics with results in public databases [36] , improved methods for 103 genetic manipulation of arthropods (that have led to field trials) [37] [38] [39] [40] [41] [42] [43] , studies on 104 the influence of the mosquito midgut microbiome on pathogen transmission [44] [45] [46] , 105 studies on the impact of the insect-specific viruses on arbovirus transmission [47, 106 48] , and the use of Wolbachia endosymbiotic bacteria that prevent pathogen 107 transmission [37, [49] [50] [51] [52] . Nonetheless the opportunity to access and make best use 108 of ongoing research can be difficult, given the specialized knowledge, costs and 109 Collecting information about the current and perceived future infrastructure needs 143 of the vector biology research community and other stakeholders is an important 144 step to ensure that the services offered via Transnational Access reflect actual needs 145 of the advanced community. Here we present the findings of a survey of scientists 146 and associated stakeholders in the field of vector biology or fields that are linked to 147 vector biology such as pathogen studies, which will help to define priorities and 148 requirements within INFRAVEC-2 but should also be of interest to governments, 149 research organizations and researchers in the field. Participation numbers suggest 150 that in particular European research priorities are reflected in the results, but the 151 data can inform stakeholders worldwide. 152 153
Materials and Methods 154
Survey structure. A questionnaire (S1 Table) was sent to organizational email lists 155 infrastructures that participants would use, offered by the facilities at no cost to 171 user, 6) identification of research priorities over the next 5-10 years, and 7) 172 additional feedback. The survey was carried out from October to November 2015. 173
Respondents were given the opportunity to provide their name and institution, 174 although this was not required for completion of the questionnaire. However, all 175 respondents (n=211) identified themselves, indicating that repeat voting or vote 176 stuffing is not a concern for interpretation of the results. All results shown here are 177 anonymized, and no survey participant details published. 178 179
Results and Discussion 180
In total 211 responses were obtained (see S2 Table) . Approximately 88% of 181 respondents were from countries across Europe, with France, and then the UK 182 providing the highest numbers of responses. This suggests that the results reflect a 183 good overview of current priorities in European vector biology and vector research 184 areas. Below we summarize and analyze the data obtained in the survey. 185 186
Research areas: arthropods and pathogens relevant to survey participants. 187
Our goal was to obtain an overview of the research areas and work of survey 188 participants, which are thus likely to guide their future research needs (S1 Table, (13), tsetse flies (7), triatomines (4), tabanids/horse flies (6) 207
We also quantified the major and minor interests of survey participants (Table 2) . 208
There was a notably strong indication of research interests in arboviruses, mainly 209 affecting humans but also livestock pathogens as well. These research interests and 210 activities are likely due to the emergence and importance of arboviruses such as 211 chikungunya, Zika, Schmallenberg and bluetongue [2, 55, [61] [62] [63] . Given the 212 historically important role of malaria research also in Europe, the overall importance 213 in the vector field is not surprising. Of note was the impact of tick-borne pathogens 214 in the category "Other" and this is worth mentioning especially with the impact of 215 To describe their activities in more detail, we collected further data on the research 224 areas of interest to the survey participants (Table 3 ). In general vector biology 225 describes the research of over half of the participants, however this is a very broad 226 term. Vector ecology, behavior and control were also commonly reported. Of note, 227 genetic modification and vector immunity remain relatively small fields despite 228 important advances in these areas. Interest may increase with better tools and 229 access to new resources such as strains and facilities. The survey data showed that 230 studies of pathogens either directly or within the context of host-pathogen or 231 vector-pathogen interactions are a key area of research. This needs to be 232 emphasized as it integrates disciplines such as virology, parasitology, cell biology, 233 microbiology and genetics into the vector field. Similarly, surveillance, diagnostics 234 and epidemiology were important areas and this (alongside vector control, behavior 235 and ecology) was an indication of the applied character of many activities in the field 236 of vector-borne diseases. 237 238 
Assessment of currently available facilities 243
Knowledge of availability and/or ease of access to research infrastructures is a key 244 factor in future planning of research activities. Survey participants were therefore 245
asked to indicate their current organization's current capabilities. As shown in Table  246 4, survey participants indicated a certain level of capacity to provide vectors but also 247 material across the community. Moreover facilities for biosafety level (BSL) 2 and 3 248 experiments with vectors, animals and pathogens are available in several places. 
Assessment of infrastructure and service requirements 261
When survey participants were asked to indicate how many had requested access to 262 insectaries at BSL2 or 3 in other institutions, in total 62 positive responses were 263 received. However out of these, 18 responses indicated that access could not be 264 granted in a timely manner. This suggests that inability to consistently access secure 265 insectary facilities comprises a systematic weakness that impedes research on 266
vector-pathogen interactions and may also explain the weaker interest in vector 267 immunity studies, for example. The relevant secure insectary facilities exist in Europe 268 (Table 4) , and thus a mutualized network of insectaries at BSL2 and 3 could resolve 269 access limitations and promote elevated levels of vector research under BSL2 and 3 270 conditions. 271
272
Access needs, or provision of infected vectors or extracts from infected vectors were 273 assessed and participants were asked to indicate which pathogens or 274 facilities/services would be of interest in the context of INRFAVEC-2 where these are 275 free of cost (or the requirement for collaboration) for the end user (Table 5) . 276
Although the questions below were originally aimed at potential European users all 277 answers were taken into account. Survey data show that in particular services and 278 structures for arbovirus research would likely generate strong demand. Again this 279 may be due to the surge in research in this field described above. Similarly, BSL2 and 280 3 studies on infected vectors and insecticides as well as behavior scored highly. 281
Regarding technologies novel for the field, functional siRNA screens and imaging of 282 vectors did not score particularly high but this demand may increase in the future, 283 particularly if facilities were available for access. 284 285 The era of genomics has brought about much needed information on vector 309 genomes (see for example [68] [69] [70] ). Genetic manipulation of genomes in basic 310 biological studies of gene/sequence structure and function, and applications based 311 on genome manipulation (see for example [71] [72] [73] ) are useful tools to maximize the 312 value of this information, and for example CRISPR/Cas9-mediated genome 313 manipulation is an important technical advance also for the vector field [74, 75] . We 314 therefore asked survey participants about their interest in applying genome editing 315 technologies within their work. As shown in Table 7 , there was particularly strong 316 interest in genetic manipulation of aedine mosquitoes. Culicoides midges seemed at 317 present a less popular subject, probably at least in part because the community is 318 small as mentioned above, as well as that the technologies have not yet been 319 applied to this system or general issues with establishing colonies of important 320 midge vector species. Among the category "Other", ticks stood out. (17), phlebotomines (5), Culex spec. and tsetse flies (both 4). 329
Studies on vectors (infected, uninfected or genetically modified) often include 330
components that analyze behavior and ecology. A further section of this survey 331 therefore focused on a number of specific potential requirements in this area. As 332 indicated in Table 8 , the interest to work in field sites in endemic countries if access 333 could be provided, as well as standardized behavioral assays and bioassays for 334 vectors generated strong positive responses. This suggested a need for these in the 335 vector research community. Positive responses for large cage studies (controlled 336 indoors or semi-controlled outdoors) were also strong considering that such 337 applications are very specialized, and the facilities are rare. However, this illustrates 338 the potential contribution of a Research Infrastructure project, because community 339 mutualization of rare infrastructures can allow access to state of the art facilities for 340 researchers with occasional needs. In the future, the possibility to access such 341 facilities may become stronger as more genetically modified vectors will be assessed 342 in pre-release assays. Few positive responses for electrophysiology experiments 343 were obtained, suggesting that there is no major need for additional facilities 344 beyond what is already in place. 345 346 collections generated high interest. However, the practices of systematics may be at 360 a juncture, because the technological capacity will soon be available to whole-361 genome sequence large numbers of unidentified individuals of a putative vector 362 clade, and cluster them bioinformatically to determine phylogenetic relatedness. 363
These results will need to be compared to existing collections, including voucher 364 specimens. Perhaps surprisingly, new reference and cloned vector cell lines did not 365 score highly but these may be of interest to smaller research areas such as virologists 366 who carry out particular types of studies. Cell lines may be of less interest in malaria 367 vector research where the biology is not consistent with simple cell models of 368 Very few responses to "Other needs" given; one example: training of field workers and students in field identification. 400
Survey participants were also asked to give their opinions in a text field on research 401 priorities for vector biology over the next 5-10 years. Answers varied but some key 402 areas were identified: 1) Vector interactions with hosts and pathogens, including 403 vector competence and transmission; 2) Insecticide resistance and novel 404 
Introduction
A consortium of European institutions based in the former FP7/INFRAVEC project is responding to the new H2020 call "Integrating Activities for Advanced Communities" of the European Research Infrastructures (RI) Programme under the item "Research Infrastructures for the control of vector-borne diseases". The primary purpose of an "integrated infrastructure" is to provide the EU scientific community with access to its network of RI facilities and services, without charge to the end user, at the state-of-the art premises of participating institutions. Access to the specialized RI enables European researchers and SME to carry out experiments beyond their current capacities. The RI consortium will provide enabling infrastructures and support for research on disease vectors and their pathogens. We have listed possible RI and services within the following questionnaire, and we would like to solicit as wide as possible feedback from potential users in order to understand the major needs of the vector biology community. Your particular requirements and feedback will have strong impact on how the project will be structured, as this "integrated infrastructure" needs to be tightly tailored to, and inspired by real community needs. Please, take a minute to fill in a short questionnaire (~15 min) that will help us mobilize necessary resources for the future of our community.
Please feel free to forward this email to relevant colleagues. The primary target audience is EU insect vector researchers and SME, but we welcome replies from outside the EU as well. All individual replies and identity information will be kept confidential. Questions can be addressed to email: infravec-survey@pasteur.fr Please complete this form as soon as you can. The survey will close November 25th 2015.
Thank you for your collaboration.
Q1. Please provide your name and contact details.

Title
First name
Supporting information S1 Table. The INFRAVEC-2 Survey Questionnaire, as sent out to participants. A brief description of the INRFAVEC-2 community is given, and the aims of the questionnaire explained.
Last name
Position
Organization
Country
Email (optional)
Providing an email address is optional, but will permit us to keep you informed about the consortium; contact information will not be shared with other parties. Yes No Q6. Which infrastructure services offered to European users would you be likely to use, with user access costs paid by a Horizon 2020 Research Infrastructure consortium (i.e., at no charge to the end-user). Items provided as user access or custom service, which does not require scientific collaboration with the providing facility.
Q2. Please identify the arthropod vectors and/or vector borne pathogens that you research
